Thailand - Delayed Quote THB

JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. (JSP.BK)

1.8100
0.0000
(0.00%)
At close: May 13 at 4:36:43 PM GMT+7

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in THB.
NameTitlePayExercisedYear Born
Mr. Sittichai Daengprasert President, CEO, Executive VP of Research & Innovation and Director -- -- 1983
Ms. Jirada Daengprasert CFO, EVP of Finance, Accounting, Human Capital & Corporate Services, Co. Secretary and Director -- -- 1985
Mr. Sorasit Daengprasert Executive VP of Production & Operations and Director -- -- 1987
Mr. Pissanu Daengprasert Executive VP of Sales & Marketing and Director -- -- 1983
Mr. Kriangkrai Rungruangthaweekul Head of Investor Relations, Head of Compliance & VP of Finance -- -- 1986
Mr. Sirisak Manitkunakarn Head of Internal Audit -- -- --
Ms. Nongnuch Cheawpattayakorn Quality Assurance Senior Manager -- -- --
Mr. Danaisuan Kunarojanasombhat Plant Senior Manager -- -- --

JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.

No. 255, 257, Sathu Pradit 58
Bang Pongphang Yan Nawa
Bangkok, 10120
Thailand
66 2 284 1218 https://www.jsppharma.com
Industry: 
Packaged Foods

Description

JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. develops, produces, and sells pharmaceutical, dietary supplementary, traditional medicine, and herbal products in Thailand. It also involved in manufacturing and selling hemodialysis products and supplies, purified water systems for industrial purposes, and related medical supplies; and service of laboratory research, scientific test and analysis, training and seminar, and consultancy for research fund application businesses. The company was founded in 1954 and is based in Bangkok, Thailand.

Corporate Governance

JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

August 28, 2024 at 12:00 AM UTC

Ex-Dividend Date